Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Profile Publications(22)
XB-PERS-1160

Julie C. Baker

Associate Professor

Stanford University
Stanford, CA
94305, USA

jbaker@stanford.edu
www.stanford.edu/group/bakerlab/Welcome.html

Phone:  650-736-0278

Research Description

With the complete sequence of the human and mouse genomes on the horizon, the critical next step in genomic analysis is to provide functional criteria for the newly discovered proteins. Understanding the diverse protein functions present within complex genomes must encompass many different and unique approaches. These functional approaches currently include two-hybrid screens for interacting proteins, microarray techniques for visualizing expression complexity, and other assays designed to elucidate specialized functions. We have developed one such functional-based assay that we are utilizing to identify potentially hundreds of molecules that can alter specific cell-fate responses. 

Our main focus is to understand the signals necessary for patterning and specifying diverse cellular fates during gastrulation in the mouse. Mouse gastrulation, even more so than amphibian and teleost gastrulation, is a period of vast differentiation and growth. During this stage, the mouse embryo transitions from having only two cell types, to having hundreds. Although an incredibly rich source of cell signaling, the mouse gastrula has not been used by molecular biologists to mine for molecules. This is mainly due to the size (100mm) and inaccessibility of the mouse gastrula, which therefore precludes the effective use of biochemistry, embryology and molecular assays in general. 

We have devised a screen that taps the identity of molecules involved in cell-fate specification during mouse gastrulation. This approach delivers random combinations of cDNAs from mouse gastrula libraries into the more tractable Xenopus embryo. We then observe these embryos for changes in specific marker gene expression, indicating changes – positive or negative – in cell-fate. We are particularly interested in the alteration of mesodermal, endodermal, neural, endothelial and somitic cell-fate decisions. By proceeding with a trial run of the screen, we have already identified 17 molecules, 8 of which have no previously understood function. 

Of the 8 unexplored molecules identified, we are currently characterizing 4 in-depth. One of these inhibits vasculogenesis and causes the ectopic formation of neurons. Another is an endogenous inhibitor of MAP Kinase signaling and is required for the formation of mesodermal cells. Two others can induce the formation of endoderm. Studies on these proteins, and others like them, are on going in our laboratory.

Lab Memberships

Baker Lab (Principal Investigator/Director)

My Xenbase: [ Log-in / Register ]
version: [4.5.0]

Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556